Patient Square Capital Acquires Premier, Inc. for $2.6 Billion

Patient Square Capital Acquires Premier, Inc.

November 25, 2025

Healthcare Services

Premier, Inc. stockholders overwhelmingly approved Patient Square Capital’s acquisition of the company at a special meeting. The deal provides Premier shareholders $28.25 in cash per share and is expected to close on or about November 25, 2025, subject to customary closing conditions.

Patient Square Capital Acquires Patterson Companies

April 17, 2025

Healthcare Services

Patterson Companies entered into a definitive agreement to be acquired by Patient Square Capital in a $4.1 billion transaction (about $31.35 per share in cash). The acquisition completed on April 17, 2025, and Patterson’s common stock is no longer traded on the Nasdaq Global Select Market.

Patient Square Capital Acquires SOC Telemed, Inc.

February 3, 2022

Healthcare Services

Patient Square Capital agreed to acquire SOC Telemed, Inc., the largest U.S. provider of acute care telemedicine, in an all-cash transaction valuing SOC Telemed at $3.00 per share. The deal takes SOC Telemed private and will provide capital and industry expertise to expand the company’s clinical capabilities, innovate its Telemed IQ platform and grow its footprint across hospitals, post-acute and value-based care organizations.

Patient Square Capital Acquires Paradigm

February 12, 2026

Healthcare Services

Paradigm, a specialty care management organization focused on complex injuries and diagnoses, entered into a definitive agreement to be acquired by Patient Square Capital. The transaction is expected to close in the first half of 2026 and represents the end of Paradigm’s partnership with OMERS Private Equity.

Patient Square Capital Acquires Hanger, Inc.

October 3, 2022

Healthcare Services

Hanger, Inc. announced it has completed its previously announced acquisition by Patient Square Capital in an all-cash deal. Hanger stockholders received $18.75 per share and Hanger became a private company, with its NYSE listing removed.

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.